Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 8/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17867644 | 0.79 | CYP3A4 (0.39) | CYP1A2CYP3A4CYP2D6CYP2C19TSHR | |
| SCHEMBL17886475 | 0.77 | PIN1 (0.31) | — | |
| SCHEMBL17867643 | 0.74 | NCOA1 (0.40) | CYP1A2CYP3A4CYP2D6CYP2C19TSHR | |
| SCHEMBL17867637 | 0.74 | PDK2 (0.33) | CLK4 | |
| SCHEMBL17886455 | 0.72 | — | — | |
| SCHEMBL17886469 | 0.71 | MEN1 (0.35) | CYP1A2CYP2C19TSHRMAPK10KDM4E | |
| SCHEMBL20011331 | 0.70 | HTR2A (0.38) | KDM4ELMNAMAPT | |
| SCHEMBL17886451 | 0.66 | PTGER4 (0.33) | KDM4E | |
| SCHEMBL17206441 | 0.66 | ASIC3 (0.40) | CYP1A2CYP3A4CYP2D6CYP2C19TSHR | |
| SCHEMBL15959705 | 0.66 | NPSR1 (0.38) | LMNATDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9793493-B2 | Organic material and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-10-17 | — | — | US | disclosed |
| US-9793493-B2 | Organic material and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-10-17 | — | — | US | disclosed |
| US-20160190472-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. | 2016-06-30 | — | — | US | disclosed |
| US-20160190472-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160190472-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | EBPL, OXA1L, HBS1L | CYP1A2 3784/4885CYP3A4 3192/4885CYP2D6 3822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.